[ORGANIZATION]
VK2735
Featured in 2 tracked stories · first seen
Also covered in
-
Viking Therapeutics reports positive Phase 2 obesity drug data
[BUSINESS] · 4 sources ·
-
Viking Therapeutics Beats Q2 Earnings Estimates, Highlights Progress on Obesity Drug VK2735
[BUSINESS] · 4 sources ·